13
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Local efficacy of cyclosporine in corneal transplant therapy

, , , &
Pages 337-343 | Received 15 Sep 1993, Accepted 18 Feb 1994, Published online: 05 Aug 2009

References

  • Chandler J. W. Immunological considerations in cornea transplantation. The Cornea, H. E. Kaufman, B. A. Barron, M. B. McDonald, S. R. Waltman. Churchill Livingstone, New York, NY 1988; 725–741
  • Williams K. A., Grutzmacher R. D., Roussel T. J., Coster D. J. A comparison of the effects of topical cyclosporine and topical steroids on rabbit corneal allograft rejection. Transplantation 1985; 39: 242–244
  • Shepherd W. F. I., Coster D. J., Fook T. C., Rice N. S. C., Jones B. R. Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br. J. Ophthalmol. 1980; 64: 148–153
  • Bell T. A.G., Easty D. L., McCullagh K. G. A placebo-controlled blind trial of cyclosporine A in prevention of corneal graft rejection in rabbits. Br. J. Ophthalmol. 1982; 66: 303–308
  • Hunter P. A., Garner A., Wilhelmus K. R., Rice N. S. C., Jones B. R. Corneal graft rejection. A new rabbit model and cyclosporine A. Br. J. Ophthalmol. 1982; 66: 292–302
  • Hunter P. A., Wilhelmus K. R., Rice N. S. C., Jones B. R. Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection. Clin. Exp. Immunol. 1981; 45: 173–177
  • Roussel T. J., Osato M. S., Wilhelmus K. R. Cyclosporine and experimental corneal transplantation. Transplant. Proc. 1983; 15: 3081–3083
  • Foets B., Missotten L., Vandervereen P., Goossens W. Prolonged survival of allogeneic grafts in rabbits treated with topically applied cyclosporine A. Systemic absorption and local immunosuppressive effect. Br. J. Ophthalmol. 1985; 69: 600–603
  • Miller K., Brady J. M., Cutright D. E. Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine. Transplantation. 1988; 45: 651–653
  • Hill J. C. The use of cyclosporine in high risk keratoplasty. Am. J. Ophthalmol. 1989; 107: 506–510
  • Hoffmann F., Wiederholdt M. Topical cyclosporin A in the treatment of corneal graft rejection. Cornea 1986; 5: 129
  • Belin M. W., Bouchard C. S., Frantz S., Chmielinska J. Topical cyclosporine in high-risk corneal transplants. Ophthalmol. 1989; 96: 1144–1150
  • Diaz-Llopis M., Menezo J. Penetration of 2% cyclosporin eyedrops into human aqueous humour. Br. J. Ophthalmol. 1989; 73: 600–603
  • Bell T. A., Hunnisett A. G. Cyclosporin A: Tissue levels following topical and systemic administration to rabbits. Br. J. Ophthalmol. 1986; 70: 852–855
  • Kaswan R. L. Intraocular penetration of topically applied cyclosporine. Transplant. Proc. 1988; 20: 650–655
  • Newton C., Gebhardt B. M., Kaufman H. E. Topically applied cyclosporine in azone prolongs corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 1988; 29: 208–215
  • Ben D. Ezra, Maftzir G., de Courten C., Timonen P. Ocular penetration of cyclosporin A. III. The human eye. Br. J. Ophthalmol. 1990a; 74: 350–352
  • Ben D. Ezra, Maftzir G. Ocular penetration of cyclosporin A. The rabbit eye. Invest. Ophthalmol. Vis. Sci. 1990b; 31: 1362–1366
  • Schoenwald R. D. Ocular drug delivery. Clin. Pharmacokin. 1990; 18: 255–269
  • Gregory C., Hietala S., Pederson N., Gregory T., Floyd-Hawkins K., Patz J. Cyclosporine pharmacokinetics in cats following topical ocular administration. Transplantation 1989; 47: 516–519
  • Sawchuk R. J., Cartier L. L. Liquid-chromatographic determination of cyclosporin A in blood and plasma. Clin. Chem. 1981; 27: 1368–1371
  • Salisbury J. D., Gebhardt B. M. Suppression of corneal allograft rejection by cyclosporin. A. Arch. Ophthalmol. 1981; 99: 1640–1643
  • Crank J. The Mathematics of Diffusion 2nd Ed. Oxford University Press. 1975; 47–48
  • Baker R. W., Lonsdale H. K. Controlled release: mechanisms and rates. Controlled Release of Biologically Active Agents, Advances in Experimental Medicine and Biology, A. C. Tanquary, R. E. Lacey. Plenum Press, New York 1974; 47: 15–72
  • Crank J. The Mathematics of Diffusion 2nd Ed. Oxford University Press. 1975; 90–91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.